Frontlight ResearchEarly access
Taking people in PolandPhase 1
Tests anti-CD19 CAR-T cells for safety in adults with B-cell non-Hodgkin lymphoma
Tests anti-CD19 CAR-T cells in adults with B-cell non-Hodgkin lymphoma.
Key facts
- Who runs it
- Wroclaw Medical University
- Where
- Wroclaw, PolandSee the site
- Trial code
- Registry title
- Phase I, Open-label, Single-center, Dose Escalation Study to Assess Safety and Tolerability of anti-CD19 CAR-T Cells in Patients with B-cell non-Hodgkin Lymphomas (CARMEN).
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 18 people, planned
- Started
- 25 Jun 2025
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional
- Record updated
- 13 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with B-cell non-Hodgkin lymphoma, such as DLBCL or high grade B-cell lymphoma, to test the safety of anti-CD19 CAR-T cells.
- Age
- 18 years or older
- Sex
- Women and men can join.
- Disease stage
- B-cell non-Hodgkin lymphoma, including DLBCL, aggressive B-cell lymphoma and high grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement. The record gives no further stage details.
Where in Poland
- Wroclaw Medical UniversityWroclaw, PolandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests anti-CD19 CAR-T cells for safety in adults with B-cell non-Hodgkin lymphomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 13 March 2026